SCHEMBL2790140

SCHEMBL2790140

C=CC(=O)CC1=CCCCC1

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 1/20 0.43
ALDH1A1 P00352 5/20 0.41
HPGD P15428 3/20 0.41
SMN1; SMN2 Q16637 5/20 0.39
NPC1 O15118 5/20 0.38
RAB9A P51151 5/20 0.38
LMNA P02545 1/20 0.38
EPHX1 P07099 2/20 0.38
MAPT P10636 1/20 0.38
NFKB1 P19838 1/20 0.38
NFKB2 Q00653 1/20 0.38
RELA Q04206 1/20 0.38
ALOX15 P16050 1/20 0.38
NPSR1 Q6W5P4 1/20 0.37
CYP1A2 P05177 1/20 0.37
POLB P06746 1/20 0.37
CYP2C19 P33261 1/20 0.37
GSTP1 P09211 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6165925 0.79 ALDH1A1 (0.45) TAAR1ALDH1A1HPGDSMN1; SMN2NPC1
SCHEMBL8170012 0.79 GSTP1 (0.46) TAAR1ALDH1A1HPGDSMN1; SMN2NPC1
Acrylic Acid SCHEMBL3278734 0.78 TAAR1 (0.48) TAAR1ALDH1A1HPGDSMN1; SMN2NPC1
SCHEMBL971269 0.78 ALDH1A1 (0.47) TAAR1ALDH1A1HPGDSMN1; SMN2NPC1
SCHEMBL909565 0.78 TAAR1 (0.38) TAAR1ALDH1A1HPGDSMN1; SMN2NPC1
SCHEMBL2127670 0.77 ALDH1A1 (0.44) TAAR1ALDH1A1HPGDSMN1; SMN2NPC1
SCHEMBL472109 0.76 KMT2A (0.41) TAAR1ALDH1A1HPGDSMN1; SMN2MAPT
SCHEMBL2901854 0.76 ALDH1A1 (0.43) TAAR1ALDH1A1HPGDSMN1; SMN2NPC1
SCHEMBL10568010 0.76 ALDH1A1 (0.46) TAAR1ALDH1A1HPGDSMN1; SMN2NPC1
SCHEMBL22607753 0.76 ALDH1A1 (0.46) TAAR1ALDH1A1HPGDSMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7812195-B2 Cyclohexenyl butenones and fragrance compositions comprising them GIVAUDAN SA (CH) 2010-10-12 US disclosed
US-20100016197-A1 Cyclohexenyl Butenones and Fragrance Compositions Comprising Them GIVAUDAN SA (CH) 2010-01-21 US disclosed
EP-2094359-A1 CYLOHEXENYL BUTENONES AND FRAGRANCE COMPOSITIONS COMPRISING THEM Givaudan SA (CH) 2009-09-02 EP disclosed
WO-2008071025-A1 CYCLOALKENYL BUTENONES AND FRAGRANCE COMPOSITIONS COMPRISING THEM GIVAUDAN SA (CH) 2008-06-19 WO disclosed
WO-2008071026-A1 CYLOHEXENYL BUTENONES AND FRAGRANCE COMPOSITIONS COMPRISING THEM GIVAUDAN SA (CH) 2008-06-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100016197-A1 Cyclohexenyl Butenones and Fragrance Compositions Comprising Them CBR3, C5, CYB5R3 TAAR1 1074/4885ALDH1A1 716/4885HPGD 367/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.